Can charcoal improve outcomes in COVID-19 infections?

COVID-19 infection causes considerable morbidity and mortality, especially to those who are aged, have impaired renal function and are obese. We propose to examine the potential utility of oral activated charcoal with the hypothesis that such treatment would lower absorption of microbiome derived to...

Descripción completa

Detalles Bibliográficos
Autores principales: Khitan, Zeid J., Khawaja, Imran, Mufson, Maurice A., Sanabria, Juan R., Abraham, Nader G., Peterson, Stephen J., Sundaram, Uma, Shapiro, Joseph I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7416710/
https://www.ncbi.nlm.nih.gov/pubmed/33254498
http://dx.doi.org/10.1016/j.mehy.2020.110176
Descripción
Sumario:COVID-19 infection causes considerable morbidity and mortality, especially to those who are aged, have impaired renal function and are obese. We propose to examine the potential utility of oral activated charcoal with the hypothesis that such treatment would lower absorption of microbiome derived toxins and ameliorate systemic oxidant stress and inflammation.

Ejemplares similares